These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 4277691

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Preliminary study of the treatment of nephrolithiasis (calcium stones) with diphosphonate.
    Oata M, Pak CY.
    Metabolism; 1974 Dec; 23(12):1167-73. PubMed ID: 4372511
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Studies on dentinogenesis in the rat. Ethane-1-hydroxy-1,1-diphosphonate (EHDP) inhibits crystal growth in predentin calcification.
    Larsson A, Larsson SE.
    Virchows Arch A Pathol Pathol Anat; 1973 Dec; 360(4):315-25. PubMed ID: 4201099
    [No Abstract] [Full Text] [Related]

  • 7. Oxalate metabolism and renal calculi.
    Menon M, Mahle CJ.
    J Urol; 1982 Jan; 127(1):148-51. PubMed ID: 7035692
    [Abstract] [Full Text] [Related]

  • 8. The effect of fenquizone on the urinary inhibitors of calcium oxalate urolithiasis.
    Cupisti A, Ciardella F, Morelli E, Dani L, Lupetti S, Luchi S, Meola M, Barsotti G.
    Contrib Nephrol; 1987 Jan; 58():184-6. PubMed ID: 3691123
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Calcium crystalluria in recurrent renal-stone formers.
    Robertson WG, Peacock M, Nordin BE.
    Lancet; 1969 Jul 05; 2(7610):21-4. PubMed ID: 4182793
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Nephrolithiasis.
    Williams HE.
    N Engl J Med; 1974 Jan 03; 290(1):33-8. PubMed ID: 4808499
    [No Abstract] [Full Text] [Related]

  • 13. [Effect of etidronate disodium (EHDP) on calcium oxalate renal stones induced by synthetic 1 alpha(OH) vitamin D3 and ethylene glycol in rats].
    Kawamura J, Nonomura M, Okada Y, Yoshida O, Takashima M, Itokawa Y.
    Hinyokika Kiyo; 1985 May 03; 31(5):749-62. PubMed ID: 3931444
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Aggregation of calcium oxalate crystals: effect of urine and various inhibitors.
    Felix R, Monod A, Broge L, Hansen NM, Fleisch H.
    Urol Res; 1977 May 03; 5(1):21-8. PubMed ID: 16372
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Inhibitory activity of whole urine: a comparison of urines from stone formers and healthy subjects.
    Ryall RL, Hibberd CM, Mazzachi BC, Marshall VR.
    Clin Chim Acta; 1986 Jan 15; 154(1):59-67. PubMed ID: 3943225
    [Abstract] [Full Text] [Related]

  • 19. The influence of disodium ethane-1-hydroxy-1,1-diphosphonate (EHDP) on the development of experimentally induced urinary stones in rats.
    Fraser D, Russell RG, Pohler O, Robertson WG, Fleisch H.
    Clin Sci; 1972 Feb 15; 42(2):197-207. PubMed ID: 5058574
    [No Abstract] [Full Text] [Related]

  • 20. Effect of sodium cellulose phosphate therapy on crystallization of calcium oxalate in urine.
    Hayashi Y, Kaplan RA, Pak CY.
    Metabolism; 1975 Nov 15; 24(11):1273-8. PubMed ID: 241892
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.